Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response.
Saved in:
| Title: | Ceritinib overcomes proteasome inhibitor resistance in multiple myeloma by suppressing the protein folding response. |
|---|---|
| Authors: | Besse A; Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kraus M; Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen., Totu T; Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich (ETH), Zurich, Switzerland; Department Materials Meet Life, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne., Buljan M; Department Materials Meet Life, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne., Janssen APA; Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University and Oncode Institute, CC Leiden., Van der Stelt M; Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University and Oncode Institute, CC Leiden., Matisikova K; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Veprkova J; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sedlarikova L; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Jurinakova T; Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Truger M; MLL Munich Leukemia Laboratory, Munich., Haferlach C; MLL Munich Leukemia Laboratory, Munich., Lopez MM; Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen., Kortum MK; Department of Internal Medicine II, University Hospital Würzburg, Würzburg., Rasche L; Department of Internal Medicine II, University Hospital Würzburg, Würzburg., Driessen C; Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen., Besse L; Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Lenka.besse@med.muni.cz. |
| Source: | Haematologica [Haematologica] 2025 Dec 11. Date of Electronic Publication: 2025 Dec 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
